Ugonna Iroku
Gastroenterology · New York, NYNPI 1467605980
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $279,648 of the $355,652 with a category attached, or 78.6%. AbbVie accounts for 73.3% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $137,506, more than ten times the $334 reported in 2019. Among gastroenterology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 440 payments — averaging $808.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$261K
- Johnson & Johnson$87K
- Takeda Pharmaceuticals U.S.A., Inc.$6K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Pfizer$289
- Phathom Pharmaceuticals, Inc.$169
- plus $777 from 13 others
What the payments were for
- Consulting fees$32,9909%
- Speaking & faculty fees$279,64879%
- Travel & lodging$29,6158%
- Food & beverage$13,4004%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 199 | $260,528 |
| Johnson & Johnson | 80 | $86,802 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $5,698 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 104 | $1,389 |
| Pfizer | 17 | $289 |
| Phathom Pharmaceuticals, Inc. | 2 | $169 |
| Exact Sciences | 2 | $164 |
| Bristol Myers Squibb | 5 | $104 |
| Novo Nordisk | 1 | $96 |
| Merck | 3 | $76 |
| Braintree Laboratories, Inc. | 3 | $73 |
| Sanofi | 2 | $59 |
| QOL Medical, LLC | 2 | $49 |
| Lilly USA, LLC | 2 | $45 |
| Redhill Biopharma Inc. | 2 | $29 |
| Ardelyx, Inc. | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$355,652 in reported general payments places this provider in the 95th percentile of 1,682 gastroenterology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 11 | $652 |
| Pantoprazole Sodium | 52 | $607 |
| Famotidine | 11 | $143 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in New York
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
- Caterina Oneto ArayaNew York$610K
- Dana LukinNew York$491K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.